Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01570972 · ClinicalTrials.gov registry record · NA
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT01570972 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 103 participants.
The verdict
NCT01570972, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.
Interventions
- BEHAVIORAL Group Cognitive Behavioral Therapy
- BEHAVIORAL Multifamily Group Psychoeducation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2010-02 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01570972
The ClinicalTrials.gov registry entry for NCT01570972 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group Cognitive Behavioral Therapy is the first listed.
NCT01570972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01570972 about?
NCT01570972 is a clinical study titled "Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis". Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experienc...
What is the current status of trial NCT01570972?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2010-02. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01570972?
The interventions under investigation include: Group Cognitive Behavioral Therapy (BEHAVIORAL), Multifamily Group Psychoeducation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01570972?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.